This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Jan 29;350(5):482-92.

doi: 10.1056/NEJMra022251.

Risks of testosterone-replacement therapy and recommendations for monitoring

Ernani Luis Rhoden¹, Abraham Morgentaler

Affiliations

PMID: 14749457
DOI: 10.1056/NEJMra022251

Review

Risks of testosterone-replacement therapy and recommendations for monitoring

Ernani Luis Rhoden et al. N Engl J Med. 2004.

. 2004 Jan 29;350(5):482-92.

doi: 10.1056/NEJMra022251.

Authors

Ernani Luis Rhoden¹, Abraham Morgentaler

Affiliation

¹ Division of Urology, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, USA.

PMID: 14749457
DOI: 10.1056/NEJMra022251

No abstract available

PubMed Disclaimer

Comment in

Hypogonadism in elderly men--what to do until the evidence comes.
Snyder PJ. Snyder PJ. N Engl J Med. 2004 Jan 29;350(5):440-2. doi: 10.1056/NEJMp038207. N Engl J Med. 2004. PMID: 14749451 No abstract available.
Risks of testosterone replacement.
Shames DA. Shames DA. N Engl J Med. 2004 May 6;350(19):2004-6; author reply 2004-6. doi: 10.1056/NEJM200405063501919. N Engl J Med. 2004. PMID: 15128905 No abstract available.
Risks of testosterone replacement.
Harris RM. Harris RM. N Engl J Med. 2004 May 6;350(19):2004-6; author reply 2004-6. N Engl J Med. 2004. PMID: 15131837 No abstract available.
Risks of testosterone replacement.
Redmond G. Redmond G. N Engl J Med. 2004 May 6;350(19):2004-6; author reply 2004-6. N Engl J Med. 2004. PMID: 15131838 No abstract available.
Risks of testosterone replacement.
Schaeffer EM, Walsh PC. Schaeffer EM, et al. N Engl J Med. 2004 May 6;350(19):2004-6; author reply 2004-6. N Engl J Med. 2004. PMID: 15131839 No abstract available.

Similar articles

Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H. Miner MM, et al. Postgrad Med. 2011 May;123(3):17-27. doi: 10.3810/pgm.2011.05.2280. Postgrad Med. 2011. PMID: 21566412
Clinical hypogonadism and androgen replacement therapy: an overview.
Ohl DA, Quallich SA. Ohl DA, et al. Urol Nurs. 2006 Aug;26(4):253-9, 269; quiz 260. Urol Nurs. 2006. PMID: 16939042 Review.
Testosterone and prostate cancer: what are the risks for middle-aged men?
Morgentaler A. Morgentaler A. Urol Clin North Am. 2011 May;38(2):119-24. doi: 10.1016/j.ucl.2011.02.002. Epub 2011 Apr 13. Urol Clin North Am. 2011. PMID: 21621078 Review.
Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
Rhoden EL, Morgentaler A. Rhoden EL, et al. Int J Impot Res. 2006 Mar-Apr;18(2):201-5. doi: 10.1038/sj.ijir.3901394. Int J Impot Res. 2006. PMID: 16177827
[Testosterone therapy].
Diemer T, Hauptmann A, Wagenlehner FM. Diemer T, et al. Urologe A. 2016 Apr;55(4):539-48; quiz 549-50. doi: 10.1007/s00120-016-0072-y. Urologe A. 2016. PMID: 27067659 Review. German.

See all similar articles

Cited by

The Effects of Aerobic Exercise Training on Testosterone Concentration in Individuals Who are Obese or Have Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Healy R, Patten R, Bauer C, Woessner MN, Bourke M, Grossmann M, Levinger I. Healy R, et al. Sports Med Open. 2024 Oct 29;10(1):117. doi: 10.1186/s40798-024-00781-x. Sports Med Open. 2024. PMID: 39467940 Free PMC article.
Developing biomedical engineering technologies for reproductive medicine.
Zhu Y, Kong B, Liu R, Zhao Y. Zhu Y, et al. Smart Med. 2022 Dec 27;1(1):e20220006. doi: 10.1002/SMMD.20220006. eCollection 2022 Dec. Smart Med. 2022. PMID: 39188735 Free PMC article. Review.
Diagnosis and treatment of hypogonadism in men seeking to preserve fertility - what are the options?
Lockie AWC, Grice P, Mathur R, Pearce I, Modgil V. Lockie AWC, et al. Int J Impot Res. 2024 Apr 30. doi: 10.1038/s41443-024-00897-4. Online ahead of print. Int J Impot Res. 2024. PMID: 38693209 Review.
Sertoli cell lysosomes and late-onset hypogonadism.
Zamoner A, Oliveira PF, Alves MG. Zamoner A, et al. Nat Aging. 2024 May;4(5):618-620. doi: 10.1038/s43587-024-00622-2. Nat Aging. 2024. PMID: 38671231 No abstract available.
Targeting dysregulated phago-/auto-lysosomes in Sertoli cells to ameliorate late-onset hypogonadism.
Deng Z, Zhao L, Li S, Chen X, Ling X, Zheng J, Yu K, Xu J, Yao C, Han S, Liang J, Feng H, Wu L, Li P, Tian R, Jing T, Tang Y, Dai Y, Yan M, Wang C, Li Z, Zhou Z. Deng Z, et al. Nat Aging. 2024 May;4(5):647-663. doi: 10.1038/s43587-024-00614-2. Epub 2024 Apr 22. Nat Aging. 2024. PMID: 38649614

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information